Osteocytic signalling pathways as therapeutic targets for bone fragility.
about
Disruption of the Cx43/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging.Glucocorticoid suppression of osteocyte perilacunar remodeling is associated with subchondral bone degeneration in osteonecrosisOsteocyte-specific WNT1 regulates osteoblast function during bone homeostasisRole and mechanism of action of sclerostin in bone.Profilin1 is expressed in osteocytes and regulates cell shape and migration.Connexin43 and the Intercellular Signaling Network Regulating Skeletal Remodeling.An Emerging Regulatory Landscape for Skeletal Development.The Role of the Osteocyte in Bone and Nonbone Disease.Osteocyte regulation of orthodontic force-mediated tooth movement via RANKL expression.Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth.Osteocytogenesis: Roles of Physicochemical Factors, Collagen Cleavage and Exogenous Molecules.Mechanically induced bone formation is not sensitive to local osteocyte density in rat vertebral cancellous bone.The Expanding Life and Functions of Osteogenic Cells: From Simple Bone-Making Cells to Multifunctional Cells and Beyond.The brains of the bones: how osteocytes use WNT1 to control bone formation.Cx43 overexpression in osteocytes prevents osteocyte apoptosis and preserves cortical bone quality in aging mice.Reversal of loss of bone mass in old mice treated with mefloquine
P2860
Q33638902-B6D8D41F-5BD4-4A5A-BB14-ABEA1443781FQ37714895-E652B89A-5C00-4E14-A983-CA3E64974C2EQ38719412-5CE8F851-8FF5-411A-91AB-E4F0833CADC6Q38807230-8B6BD86F-0D82-4761-8481-C3AC93F22D1FQ38944712-C2808123-D780-4AB6-B926-36037362465EQ38970626-90CF4A21-9B5E-459F-8699-9C8E1CA36852Q38999018-9EA145C7-BF5A-429F-897D-EE3DECF6AD28Q39107516-EAFD59CE-E814-4F9C-AB79-319423C7017CQ41459925-83E07E98-7AEA-4F63-907E-ECBCB28D04DAQ47141750-5B143C41-8E59-40C5-9AD0-A7EF920CD7FDQ47198428-DA8D33C3-3CDB-462B-85A7-8EE15B1F8D62Q47761047-703E3D66-43E7-40F5-8EE1-A3DB0F66DB73Q50069952-4CDC5181-662F-4852-A7CD-E9D7E6E3F22FQ50936995-BC1A3A58-4E6D-4432-A7E9-7620D352E47FQ55518200-32884BC3-4808-42BC-B6C0-0E68F920DF87Q56336954-9DEAF840-FED6-4105-86A9-399E4B016C0B
P2860
Osteocytic signalling pathways as therapeutic targets for bone fragility.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Osteocytic signalling pathways as therapeutic targets for bone fragility.
@en
type
label
Osteocytic signalling pathways as therapeutic targets for bone fragility.
@en
prefLabel
Osteocytic signalling pathways as therapeutic targets for bone fragility.
@en
P2860
P356
P1476
Osteocytic signalling pathways as therapeutic targets for bone fragility.
@en
P2860
P2888
P304
P356
10.1038/NRENDO.2016.71
P577
2016-05-27T00:00:00Z